PFBT
CGON icon

Parkside Financial Bank & Trust’s CG Oncology CGON Stock Holding History

Parkside Financial Bank & Trust’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35K Hold
20
– – ﹤0.01% 2245
2025
Q4 		$831 Hold
20
– – ﹤0.01% 2401
2025
Q3 		$806 Hold
20
– – ﹤0.01% 2373
2025
Q2 		$520 Hold
20
– – ﹤0.01% 2528
2025
Q1 		$490 Buy
+20
New +$563 ﹤0.01% 2407

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Parkside Financial Bank & Trust's CGON Position: Q1 2026 in Review

Parkside Financial Bank & Trust held its CG Oncology (CGON) position steady in Q1 2026 at 20 shares worth $1.35K. The position accounts for ﹤0.01% of the portfolio, ranked #2245.

Parkside Financial Bank & Trust first reported a position in CGON in Q1 2025 and has held it in 5 quarters since. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Parkside Financial Bank & Trust held 20 shares of CG Oncology worth $1.35K as of Q1 2026.
  • Parkside Financial Bank & Trust left its CG Oncology share count unchanged in Q1 2026.
  • CG Oncology made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #2245 holding.
  • Parkside Financial Bank & Trust first reported a position in CG Oncology in Q1 2025 and has held it in 5 quarters since.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.